0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Aqueous Shunts and Stents for Glaucoma Market Research Report 2026
Published Date: 2026-01-20
|
Report Code: QYRE-Auto-37W18786
Home | Market Reports | Health| Vision Care
Global Aqueous Shunts and Stents for Glaucoma Market Research Report 2024
BUY CHAPTERS

Global Aqueous Shunts and Stents for Glaucoma Market Research Report 2026

Code: QYRE-Auto-37W18786
Report
2026-01-20
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Aqueous Shunts and Stents for Glaucoma Market Size

The global Aqueous Shunts and Stents for Glaucoma market was valued at US$ 1568 million in 2025 and is anticipated to reach US$ 3960 million by 2032, at a CAGR of 14.4% from 2026 to 2032.

Aqueous Shunts and Stents for Glaucoma Market

Aqueous Shunts and Stents for Glaucoma Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Aqueous Shunts and Stents for Glaucoma competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Glaucoma is an eye disease characterized by elevated intraocular pressure (IOP) that can lead to irreversible damage to the optic nerve. Glaucoma aqueous shunts and stents are medical devices used to treat glaucoma that are implanted in the eye to create a new outflow path for aqueous humor, thereby reducing intraocular pressure.
The North American market for Aqueous Shunts and Stents for Glaucoma is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Aqueous Shunts and Stents for Glaucoma is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Aqueous Shunts and Stents for Glaucoma include AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Nova Eye Medical, Glaukos Corp, Alcon, iSTAR Medical, Henan Universe, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Aqueous Shunts and Stents for Glaucoma market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Aqueous Shunts and Stents for Glaucoma. The Aqueous Shunts and Stents for Glaucoma market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Aqueous Shunts and Stents for Glaucoma market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Aqueous Shunts and Stents for Glaucoma manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Aqueous Shunts and Stents for Glaucoma Market Report

Report Metric Details
Report Name Aqueous Shunts and Stents for Glaucoma Market
Accounted market size in 2025 US$ 1568 million
Forecasted market size in 2032 US$ 3960 million
CAGR 14.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Trabecular Meshwork-Schlemm Canal Drainage
  • Subconjunctival Drainage
  • Other
by Application
  • Hospitals
  • Ophthalmology Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Nova Eye Medical, Glaukos Corp, Alcon, iSTAR Medical, Henan Universe, Ocular Therapeutix, PolyActiva, Health Guard Biomed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Aqueous Shunts and Stents for Glaucoma manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Aqueous Shunts and Stents for Glaucoma sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Aqueous Shunts and Stents for Glaucoma Market growing?

Ans: The Aqueous Shunts and Stents for Glaucoma Market witnessing a CAGR of 14.4% during the forecast period 2026-2032.

What is the Aqueous Shunts and Stents for Glaucoma Market size in 2032?

Ans: The Aqueous Shunts and Stents for Glaucoma Market size in 2032 will be US$ 3960 million.

Who are the main players in the Aqueous Shunts and Stents for Glaucoma Market report?

Ans: The main players in the Aqueous Shunts and Stents for Glaucoma Market are AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Nova Eye Medical, Glaukos Corp, Alcon, iSTAR Medical, Henan Universe, Ocular Therapeutix, PolyActiva, Health Guard Biomed

What are the Application segmentation covered in the Aqueous Shunts and Stents for Glaucoma Market report?

Ans: The Applications covered in the Aqueous Shunts and Stents for Glaucoma Market report are Hospitals, Ophthalmology Clinics, Other

What are the Type segmentation covered in the Aqueous Shunts and Stents for Glaucoma Market report?

Ans: The Types covered in the Aqueous Shunts and Stents for Glaucoma Market report are Trabecular Meshwork-Schlemm Canal Drainage, Subconjunctival Drainage, Other

1 Aqueous Shunts and Stents for Glaucoma Market Overview
1.1 Product Definition
1.2 Aqueous Shunts and Stents for Glaucoma by Type
1.2.1 Global Aqueous Shunts and Stents for Glaucoma Market Value by Type: 2025 vs 2032
1.2.2 Trabecular Meshwork-Schlemm Canal Drainage
1.2.3 Subconjunctival Drainage
1.2.4 Other
1.3 Aqueous Shunts and Stents for Glaucoma by Application
1.3.1 Global Aqueous Shunts and Stents for Glaucoma Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Ophthalmology Clinics
1.3.4 Other
1.4 Global Aqueous Shunts and Stents for Glaucoma Market Size Estimates and Forecasts
1.4.1 Global Aqueous Shunts and Stents for Glaucoma Revenue 2021–2032
1.4.2 Global Aqueous Shunts and Stents for Glaucoma Sales 2021–2032
1.4.3 Global Aqueous Shunts and Stents for Glaucoma Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Aqueous Shunts and Stents for Glaucoma Market Competition by Manufacturers
2.1 Global Aqueous Shunts and Stents for Glaucoma Sales Market Share by Manufacturers (2021–2026)
2.2 Global Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Aqueous Shunts and Stents for Glaucoma Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Aqueous Shunts and Stents for Glaucoma, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Aqueous Shunts and Stents for Glaucoma, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Aqueous Shunts and Stents for Glaucoma, Product Types and Applications
2.7 Global Key Manufacturers of Aqueous Shunts and Stents for Glaucoma, Date of Entry into the Industry
2.8 Global Aqueous Shunts and Stents for Glaucoma Market Competitive Situation and Trends
2.8.1 Global Aqueous Shunts and Stents for Glaucoma Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Aqueous Shunts and Stents for Glaucoma Players Market Share by Revenue
2.8.3 Global Aqueous Shunts and Stents for Glaucoma Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Aqueous Shunts and Stents for Glaucoma Market Scenario by Region
3.1 Global Aqueous Shunts and Stents for Glaucoma Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Aqueous Shunts and Stents for Glaucoma Sales by Region: 2021–2032
3.2.1 Global Aqueous Shunts and Stents for Glaucoma Sales by Region: 2021–2026
3.2.2 Global Aqueous Shunts and Stents for Glaucoma Sales by Region: 2027–2032
3.3 Global Aqueous Shunts and Stents for Glaucoma Revenue by Region: 2021–2032
3.3.1 Global Aqueous Shunts and Stents for Glaucoma Revenue by Region: 2021–2026
3.3.2 Global Aqueous Shunts and Stents for Glaucoma Revenue by Region: 2027–2032
3.4 North America Aqueous Shunts and Stents for Glaucoma Market Facts & Figures by Country
3.4.1 North America Aqueous Shunts and Stents for Glaucoma Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Aqueous Shunts and Stents for Glaucoma Sales by Country (2021–2032)
3.4.3 North America Aqueous Shunts and Stents for Glaucoma Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aqueous Shunts and Stents for Glaucoma Market Facts & Figures by Country
3.5.1 Europe Aqueous Shunts and Stents for Glaucoma Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Aqueous Shunts and Stents for Glaucoma Sales by Country (2021–2032)
3.5.3 Europe Aqueous Shunts and Stents for Glaucoma Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aqueous Shunts and Stents for Glaucoma Market Facts & Figures by Region
3.6.1 Asia Pacific Aqueous Shunts and Stents for Glaucoma Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Aqueous Shunts and Stents for Glaucoma Sales by Region (2021–2032)
3.6.3 Asia Pacific Aqueous Shunts and Stents for Glaucoma Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Aqueous Shunts and Stents for Glaucoma Market Facts & Figures by Country
3.7.1 Latin America Aqueous Shunts and Stents for Glaucoma Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Aqueous Shunts and Stents for Glaucoma Sales by Country (2021–2032)
3.7.3 Latin America Aqueous Shunts and Stents for Glaucoma Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Aqueous Shunts and Stents for Glaucoma Market Facts & Figures by Country
3.8.1 Middle East and Africa Aqueous Shunts and Stents for Glaucoma Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Aqueous Shunts and Stents for Glaucoma Sales by Country (2021–2032)
3.8.3 Middle East and Africa Aqueous Shunts and Stents for Glaucoma Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aqueous Shunts and Stents for Glaucoma Sales by Type (2021–2032)
4.1.1 Global Aqueous Shunts and Stents for Glaucoma Sales by Type (2021–2026)
4.1.2 Global Aqueous Shunts and Stents for Glaucoma Sales by Type (2027–2032)
4.1.3 Global Aqueous Shunts and Stents for Glaucoma Sales Market Share by Type (2021–2032)
4.2 Global Aqueous Shunts and Stents for Glaucoma Revenue by Type (2021–2032)
4.2.1 Global Aqueous Shunts and Stents for Glaucoma Revenue by Type (2021–2026)
4.2.2 Global Aqueous Shunts and Stents for Glaucoma Revenue by Type (2027–2032)
4.2.3 Global Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Type (2021–2032)
4.3 Global Aqueous Shunts and Stents for Glaucoma Price by Type (2021–2032)
5 Segment by Application
5.1 Global Aqueous Shunts and Stents for Glaucoma Sales by Application (2021–2032)
5.1.1 Global Aqueous Shunts and Stents for Glaucoma Sales by Application (2021–2026)
5.1.2 Global Aqueous Shunts and Stents for Glaucoma Sales by Application (2027–2032)
5.1.3 Global Aqueous Shunts and Stents for Glaucoma Sales Market Share by Application (2021–2032)
5.2 Global Aqueous Shunts and Stents for Glaucoma Revenue by Application (2021–2032)
5.2.1 Global Aqueous Shunts and Stents for Glaucoma Revenue by Application (2021–2026)
5.2.2 Global Aqueous Shunts and Stents for Glaucoma Revenue by Application (2027–2032)
5.2.3 Global Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Application (2021–2032)
5.3 Global Aqueous Shunts and Stents for Glaucoma Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AbbVie Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Santen Pharmaceutical
6.2.1 Santen Pharmaceutical Company Information
6.2.2 Santen Pharmaceutical Description and Business Overview
6.2.3 Santen Pharmaceutical Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Santen Pharmaceutical Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.2.5 Santen Pharmaceutical Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Company Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Johnson and Johnson Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Advanced Ophthalmic Innovations (AOI)
6.4.1 Advanced Ophthalmic Innovations (AOI) Company Information
6.4.2 Advanced Ophthalmic Innovations (AOI) Description and Business Overview
6.4.3 Advanced Ophthalmic Innovations (AOI) Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Advanced Ophthalmic Innovations (AOI) Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.4.5 Advanced Ophthalmic Innovations (AOI) Recent Developments/Updates
6.5 New World Medical
6.5.1 New World Medical Company Information
6.5.2 New World Medical Description and Business Overview
6.5.3 New World Medical Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 New World Medical Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.5.5 New World Medical Recent Developments/Updates
6.6 Nova Eye Medical
6.6.1 Nova Eye Medical Company Information
6.6.2 Nova Eye Medical Description and Business Overview
6.6.3 Nova Eye Medical Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Nova Eye Medical Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.6.5 Nova Eye Medical Recent Developments/Updates
6.7 Glaukos Corp
6.7.1 Glaukos Corp Company Information
6.7.2 Glaukos Corp Description and Business Overview
6.7.3 Glaukos Corp Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Glaukos Corp Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.7.5 Glaukos Corp Recent Developments/Updates
6.8 Alcon
6.8.1 Alcon Company Information
6.8.2 Alcon Description and Business Overview
6.8.3 Alcon Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Alcon Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.8.5 Alcon Recent Developments/Updates
6.9 iSTAR Medical
6.9.1 iSTAR Medical Company Information
6.9.2 iSTAR Medical Description and Business Overview
6.9.3 iSTAR Medical Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 iSTAR Medical Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.9.5 iSTAR Medical Recent Developments/Updates
6.10 Henan Universe
6.10.1 Henan Universe Company Information
6.10.2 Henan Universe Description and Business Overview
6.10.3 Henan Universe Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Henan Universe Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.10.5 Henan Universe Recent Developments/Updates
6.11 Ocular Therapeutix
6.11.1 Ocular Therapeutix Company Information
6.11.2 Ocular Therapeutix Description and Business Overview
6.11.3 Ocular Therapeutix Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Ocular Therapeutix Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.11.5 Ocular Therapeutix Recent Developments/Updates
6.12 PolyActiva
6.12.1 PolyActiva Company Information
6.12.2 PolyActiva Description and Business Overview
6.12.3 PolyActiva Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 PolyActiva Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.12.5 PolyActiva Recent Developments/Updates
6.13 Health Guard Biomed
6.13.1 Health Guard Biomed Company Information
6.13.2 Health Guard Biomed Description and Business Overview
6.13.3 Health Guard Biomed Aqueous Shunts and Stents for Glaucoma Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Health Guard Biomed Aqueous Shunts and Stents for Glaucoma Product Portfolio
6.13.5 Health Guard Biomed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aqueous Shunts and Stents for Glaucoma Industry Chain Analysis
7.2 Aqueous Shunts and Stents for Glaucoma Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aqueous Shunts and Stents for Glaucoma Production Mode & Process Analysis
7.4 Aqueous Shunts and Stents for Glaucoma Sales and Marketing
7.4.1 Aqueous Shunts and Stents for Glaucoma Sales Channels
7.4.2 Aqueous Shunts and Stents for Glaucoma Distributors
7.5 Aqueous Shunts and Stents for Glaucoma Customer Analysis
8 Aqueous Shunts and Stents for Glaucoma Market Dynamics
8.1 Aqueous Shunts and Stents for Glaucoma Industry Trends
8.2 Aqueous Shunts and Stents for Glaucoma Market Drivers
8.3 Aqueous Shunts and Stents for Glaucoma Market Challenges
8.4 Aqueous Shunts and Stents for Glaucoma Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Aqueous Shunts and Stents for Glaucoma Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Aqueous Shunts and Stents for Glaucoma Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Aqueous Shunts and Stents for Glaucoma Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Aqueous Shunts and Stents for Glaucoma Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Aqueous Shunts and Stents for Glaucoma Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Aqueous Shunts and Stents for Glaucoma Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Aqueous Shunts and Stents for Glaucoma Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Aqueous Shunts and Stents for Glaucoma Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Aqueous Shunts and Stents for Glaucoma, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Aqueous Shunts and Stents for Glaucoma, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Aqueous Shunts and Stents for Glaucoma, Product Types and Applications
 Table 12. Global Key Manufacturers of Aqueous Shunts and Stents for Glaucoma, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Aqueous Shunts and Stents for Glaucoma Companies by Tier (Tier 1, Tier 2, Tier 3), based on Aqueous Shunts and Stents for Glaucoma Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Aqueous Shunts and Stents for Glaucoma Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Aqueous Shunts and Stents for Glaucoma Sales by Region (K Units), 2021–2026
 Table 18. Global Aqueous Shunts and Stents for Glaucoma Sales Market Share by Region (2021–2026)
 Table 19. Global Aqueous Shunts and Stents for Glaucoma Sales by Region (K Units), 2027–2032
 Table 20. Global Aqueous Shunts and Stents for Glaucoma Sales Market Share by Region (2027–2032)
 Table 21. Global Aqueous Shunts and Stents for Glaucoma Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Region (2021–2026)
 Table 23. Global Aqueous Shunts and Stents for Glaucoma Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Region (2027–2032)
 Table 25. North America Aqueous Shunts and Stents for Glaucoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Aqueous Shunts and Stents for Glaucoma Sales by Country (K Units), 2021–2026
 Table 27. North America Aqueous Shunts and Stents for Glaucoma Sales by Country (K Units), 2027–2032
 Table 28. North America Aqueous Shunts and Stents for Glaucoma Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Aqueous Shunts and Stents for Glaucoma Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Aqueous Shunts and Stents for Glaucoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Aqueous Shunts and Stents for Glaucoma Sales by Country (K Units), 2021–2026
 Table 32. Europe Aqueous Shunts and Stents for Glaucoma Sales by Country (K Units), 2027–2032
 Table 33. Europe Aqueous Shunts and Stents for Glaucoma Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Aqueous Shunts and Stents for Glaucoma Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Aqueous Shunts and Stents for Glaucoma Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Aqueous Shunts and Stents for Glaucoma Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Aqueous Shunts and Stents for Glaucoma Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Aqueous Shunts and Stents for Glaucoma Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Aqueous Shunts and Stents for Glaucoma Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Aqueous Shunts and Stents for Glaucoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Aqueous Shunts and Stents for Glaucoma Sales by Country (K Units), 2021–2026
 Table 42. Latin America Aqueous Shunts and Stents for Glaucoma Sales by Country (K Units), 2027–2032
 Table 43. Latin America Aqueous Shunts and Stents for Glaucoma Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Aqueous Shunts and Stents for Glaucoma Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Aqueous Shunts and Stents for Glaucoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Aqueous Shunts and Stents for Glaucoma Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Aqueous Shunts and Stents for Glaucoma Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Aqueous Shunts and Stents for Glaucoma Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Aqueous Shunts and Stents for Glaucoma Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Aqueous Shunts and Stents for Glaucoma Sales (K Units) by Type (2021–2026)
 Table 51. Global Aqueous Shunts and Stents for Glaucoma Sales (K Units) by Type (2027–2032)
 Table 52. Global Aqueous Shunts and Stents for Glaucoma Sales Market Share by Type (2021–2026)
 Table 53. Global Aqueous Shunts and Stents for Glaucoma Sales Market Share by Type (2027–2032)
 Table 54. Global Aqueous Shunts and Stents for Glaucoma Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Aqueous Shunts and Stents for Glaucoma Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Type (2021–2026)
 Table 57. Global Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Type (2027–2032)
 Table 58. Global Aqueous Shunts and Stents for Glaucoma Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Aqueous Shunts and Stents for Glaucoma Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Aqueous Shunts and Stents for Glaucoma Sales (K Units) by Application (2021–2026)
 Table 61. Global Aqueous Shunts and Stents for Glaucoma Sales (K Units) by Application (2027–2032)
 Table 62. Global Aqueous Shunts and Stents for Glaucoma Sales Market Share by Application (2021–2026)
 Table 63. Global Aqueous Shunts and Stents for Glaucoma Sales Market Share by Application (2027–2032)
 Table 64. Global Aqueous Shunts and Stents for Glaucoma Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Aqueous Shunts and Stents for Glaucoma Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Application (2021–2026)
 Table 67. Global Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Application (2027–2032)
 Table 68. Global Aqueous Shunts and Stents for Glaucoma Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Aqueous Shunts and Stents for Glaucoma Price (US$/Unit) by Application (2027–2032)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. AbbVie Aqueous Shunts and Stents for Glaucoma Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. Santen Pharmaceutical Company Information
 Table 76. Santen Pharmaceutical Description and Business Overview
 Table 77. Santen Pharmaceutical Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Santen Pharmaceutical Aqueous Shunts and Stents for Glaucoma Product
 Table 79. Santen Pharmaceutical Recent Developments/Updates
 Table 80. Johnson and Johnson Company Information
 Table 81. Johnson and Johnson Description and Business Overview
 Table 82. Johnson and Johnson Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Johnson and Johnson Aqueous Shunts and Stents for Glaucoma Product
 Table 84. Johnson and Johnson Recent Developments/Updates
 Table 85. Advanced Ophthalmic Innovations (AOI) Company Information
 Table 86. Advanced Ophthalmic Innovations (AOI) Description and Business Overview
 Table 87. Advanced Ophthalmic Innovations (AOI) Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Advanced Ophthalmic Innovations (AOI) Aqueous Shunts and Stents for Glaucoma Product
 Table 89. Advanced Ophthalmic Innovations (AOI) Recent Developments/Updates
 Table 90. New World Medical Company Information
 Table 91. New World Medical Description and Business Overview
 Table 92. New World Medical Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. New World Medical Aqueous Shunts and Stents for Glaucoma Product
 Table 94. New World Medical Recent Developments/Updates
 Table 95. Nova Eye Medical Company Information
 Table 96. Nova Eye Medical Description and Business Overview
 Table 97. Nova Eye Medical Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Nova Eye Medical Aqueous Shunts and Stents for Glaucoma Product
 Table 99. Nova Eye Medical Recent Developments/Updates
 Table 100. Glaukos Corp Company Information
 Table 101. Glaukos Corp Description and Business Overview
 Table 102. Glaukos Corp Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Glaukos Corp Aqueous Shunts and Stents for Glaucoma Product
 Table 104. Glaukos Corp Recent Developments/Updates
 Table 105. Alcon Company Information
 Table 106. Alcon Description and Business Overview
 Table 107. Alcon Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Alcon Aqueous Shunts and Stents for Glaucoma Product
 Table 109. Alcon Recent Developments/Updates
 Table 110. iSTAR Medical Company Information
 Table 111. iSTAR Medical Description and Business Overview
 Table 112. iSTAR Medical Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. iSTAR Medical Aqueous Shunts and Stents for Glaucoma Product
 Table 114. iSTAR Medical Recent Developments/Updates
 Table 115. Henan Universe Company Information
 Table 116. Henan Universe Description and Business Overview
 Table 117. Henan Universe Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Henan Universe Aqueous Shunts and Stents for Glaucoma Product
 Table 119. Henan Universe Recent Developments/Updates
 Table 120. Ocular Therapeutix Company Information
 Table 121. Ocular Therapeutix Description and Business Overview
 Table 122. Ocular Therapeutix Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Ocular Therapeutix Aqueous Shunts and Stents for Glaucoma Product
 Table 124. Ocular Therapeutix Recent Developments/Updates
 Table 125. PolyActiva Company Information
 Table 126. PolyActiva Description and Business Overview
 Table 127. PolyActiva Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. PolyActiva Aqueous Shunts and Stents for Glaucoma Product
 Table 129. PolyActiva Recent Developments/Updates
 Table 130. Health Guard Biomed Company Information
 Table 131. Health Guard Biomed Description and Business Overview
 Table 132. Health Guard Biomed Aqueous Shunts and Stents for Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Health Guard Biomed Aqueous Shunts and Stents for Glaucoma Product
 Table 134. Health Guard Biomed Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Aqueous Shunts and Stents for Glaucoma Distributors List
 Table 138. Aqueous Shunts and Stents for Glaucoma Customers List
 Table 139. Aqueous Shunts and Stents for Glaucoma Market Trends
 Table 140. Aqueous Shunts and Stents for Glaucoma Market Drivers
 Table 141. Aqueous Shunts and Stents for Glaucoma Market Challenges
 Table 142. Aqueous Shunts and Stents for Glaucoma Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Aqueous Shunts and Stents for Glaucoma
 Figure 2. Global Aqueous Shunts and Stents for Glaucoma Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Aqueous Shunts and Stents for Glaucoma Market Share by Type: 2025 & 2032
 Figure 4. Trabecular Meshwork-Schlemm Canal Drainage Product Picture
 Figure 5. Subconjunctival Drainage Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Aqueous Shunts and Stents for Glaucoma Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Aqueous Shunts and Stents for Glaucoma Market Share by Application: 2025 & 2032
 Figure 9. Hospitals
 Figure 10. Ophthalmology Clinics
 Figure 11. Other
 Figure 12. Global Aqueous Shunts and Stents for Glaucoma Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Aqueous Shunts and Stents for Glaucoma Market Size (US$ Million), 2021–2032
 Figure 14. Global Aqueous Shunts and Stents for Glaucoma Sales (K Units), 2021–2032
 Figure 15. Global Aqueous Shunts and Stents for Glaucoma Average Price (US$/Unit), 2021–2032
 Figure 16. Aqueous Shunts and Stents for Glaucoma Report Years Considered
 Figure 17. Aqueous Shunts and Stents for Glaucoma Sales Share by Manufacturers in 2025
 Figure 18. Global Aqueous Shunts and Stents for Glaucoma Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Aqueous Shunts and Stents for Glaucoma Players: Market Share by Revenue in Aqueous Shunts and Stents for Glaucoma in 2025
 Figure 20. Aqueous Shunts and Stents for Glaucoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Aqueous Shunts and Stents for Glaucoma Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Aqueous Shunts and Stents for Glaucoma Sales Market Share by Country (2021–2032)
 Figure 23. North America Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Country (2021–2032)
 Figure 24. United States Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Aqueous Shunts and Stents for Glaucoma Sales Market Share by Country (2021–2032)
 Figure 27. Europe Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Aqueous Shunts and Stents for Glaucoma Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Region (2021–2032)
 Figure 35. China Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Aqueous Shunts and Stents for Glaucoma Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Aqueous Shunts and Stents for Glaucoma Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Aqueous Shunts and Stents for Glaucoma Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Aqueous Shunts and Stents for Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Aqueous Shunts and Stents for Glaucoma by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Aqueous Shunts and Stents for Glaucoma by Type (2021–2032)
 Figure 55. Global Aqueous Shunts and Stents for Glaucoma Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Aqueous Shunts and Stents for Glaucoma by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Aqueous Shunts and Stents for Glaucoma by Application (2021–2032)
 Figure 58. Global Aqueous Shunts and Stents for Glaucoma Price (US$/Unit) by Application (2021–2032)
 Figure 59. Aqueous Shunts and Stents for Glaucoma Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture